A Phase 1 Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
A Phase 1 Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
The purpose of this study is to examine the potential for drug-drug interactions.
Key Inclusion Criteria:
Body mass index (BMI) within the range of ≥18.5 to ≤30.0 kilograms (kg)/square meter (m^2) at the screening.
A female participant is eligible to participate if she is not pregnant or breastfeeding, and either of the following conditions applies:
Key Exclusion Criteria:
NOTE: Other inclusion and exclusion criteria may apply.